Related Experiment Video
Updated: Feb 3, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with
Kyle Troksa1, Nikolas Kovacich1, Michael Moro1
1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado.
Insights
Central nervous system stimulants for attention-deficit/hyperactivity disorder (ADHD) may be linked to decreased weight and BMI. Evidence remains conflicting on whether these ADHD medications significantly impact height in children and adolescents.
Area of Science:
- Pediatric Neurology
- Pharmacology
- Child Psychiatry
Background:
- Central nervous system stimulants are a primary treatment for attention-deficit/hyperactivity disorder (ADHD).
- Common side effects include appetite loss and insomnia, but long-term effects on growth are debated.
- Previous research on stimulant-induced growth delay in pediatric ADHD populations has yielded conflicting results.
Purpose of the Study:
- To review current literature on the impact of central nervous system stimulants on growth parameters in children with ADHD.
- To synthesize recent findings regarding stimulant effects on height and weight in pediatric patients diagnosed with ADHD.
- To evaluate the evidence for potential growth delays associated with long-term stimulant therapy for ADHD.
Main Methods:
- A literature search was conducted using the PubMed database.
- Included studies utilized Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for ADHD diagnoses (IV, IV-TR, V).
- Nine relevant articles detailing clinical observations of height and weight in pediatric/adolescent ADHD patients on stimulant medication were analyzed.
Main Results:
- The review suggests a potential association between longer duration of stimulant treatment, higher doses, and reduced weight and body mass index (BMI) in children with ADHD.
- Evidence regarding a significant impact of stimulant use on height decreases remains conflicting.
- Current data indicates a need for further high-quality research to clarify the relationship between stimulant therapy and height changes.
Conclusions:
- Stimulant therapy for ADHD may be associated with decreased weight and BMI, particularly with longer treatment durations and higher doses.
- The effect of stimulant medications on height in children and adolescents with ADHD is not definitively established, with conflicting evidence.
- Further high-quality studies are required to ascertain the long-term effects of stimulant use on growth parameters in pediatric ADHD patients.
Abstract:
Central nervous system stimulants are a commonly used first-line treatment option for attention-deficit/hyperactivity disorder (ADHD). Stimulants are generally well tolerated, with anorexia and insomnia the most common adverse effects. However, there are some concerns with long-term use of stimulants, such as potential growth delay. Historically, data regarding this long-term adverse effect have been conflicting. In this article, we review the newer data surrounding the effects of central nervous system stimulants on growth parameters in children with ADHD. We conducted a literature search of the PubMed database; only articles using ADHD criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision; and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, were included to ensure the most up-to-date review of literature. Nine articles were identified for relevance and quality and are discussed in this review, describing clinical observations of height and weight of adolescent or pediatric patients receiving stimulant medications for ADHD therapy. In summary, this review points toward potential associations between duration of treatment and higher doses of stimulants with decreased weight and body mass index. Furthermore, this review demonstrates that evidence is still conflicting regarding the relationship between stimulant use and significant height decreases. Future studies with higher quality of evidence are needed to observe this potential adverse effect of stimulants in children and adolescents.
More Related Videos
09:37In vivo Optogenetic Stimulation of the Rodent Central Nervous System
Published on: January 15, 2015
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Population Growth
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
What is a Nervous System?
The Parasympathetic Nervous System